Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

Published:2015-01 Issue:1 Volume:16 Page:67-75
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cuzick Jack,Sestak Ivana,Cawthorn Simon,Hamed Hisham,Holli Kaija,Howell Anthony,Forbes John F

Funder

Cancer Research UK

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Oncology

Reference19 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Tamoxifen and contralateral breast cancer;Cuzick;Lancet,1985

3. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study;Fisher;J Natl Cancer Inst,2005

4. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study;Fisher;J Natl Cancer Inst,1998

5. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial;Powles;J Natl Cancer Inst,2007

Cited by 367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada;JAMA Network Open;2024-09-12

2. Breast Cancer Risk Assessment Tool (BCRAT) and long-term breast cancer mortality in the Women's Health Initiative;Breast Cancer Research and Treatment;2024-09-10

3. Ductal Carcinoma In Situ;Hematology/Oncology Clinics of North America;2024-08

4. Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial;Contemporary Clinical Trials;2024-07

5. Radial sclerosing lesions found on core needle biopsy: excision can be safely avoided;Histopathology;2024-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3